HILLHAVEN CORP
S-3/A, 1994-11-08
NURSING & PERSONAL CARE FACILITIES
Previous: POGO PRODUCING CO, 10-Q, 1994-11-08
Next: SPIEGEL INC, SC 13G/A, 1994-11-08








               As  filed with  the  Securities and  Exchange  Commission on
          November 8, 1994

                                        Registration No. 33-55995     

                          SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C. 20549
             
                                   AMENDMENT NO. 1
                                          TO     
                                       FORM S-3

                                REGISTRATION STATEMENT
                                        UNDER
                              THE SECURITIES ACT OF 1933


                              THE HILLHAVEN CORPORATION
                (Exact name of registrant as specified in its charter)

                         Nevada                             91-1459952
             (State or other jurisdiction                (I.R.S. Employer
           of incorporation or organization)           Identification No.)
                            
                                 1148 Broadway Plaza
                               Tacoma, Washington 98402
                                    (206) 572-4901
                 (Address, including zip code, and telephone number,
          including area code, of registrant's principal executive offices)


                                  RICHARD P. ADCOCK
                                Senior Vice President,
                            Secretary and General Counsel
                              The Hillhaven Corporation
                                 1148 Broadway Plaza
                               Tacoma, Washington 98402
                                    (206) 572-4901
              (Name, address, including zip code, and telephone number,
                      including area code, of agent for service)

               Approximate  date of  commencement of  proposed sale  to the
          public:   As soon as practicable after the effective date of this
          Registration Statement. 

               If the  only securities  being registered  on this Form  are
          being  offered  pursuant  to  dividend  or  interest reinvestment
          plans, please check the following box. / /

               If any of the  securities being registered on this  Form are
          to be offered  on a delayed or continuous basis  pursuant to Rule
          415  under  the Securities  Act  of 1933,  other  than securities
          offered only in connection with dividend or interest reinvestment
          plans, please check the following box. /X/





          <PAGE>
<PAGE>



               The Registrant hereby amends this  Registration Statement on
          such date or  dates as may  be necessary  to delay its  effective
          date  until the Registrant  shall file a  further amendment which
          specifically   states  that  this  Registration  Statement  shall
          thereafter become  effective in  accordance with Section  8(a) of
          the  Securities   Act  of  1933,   as  amended,  or   until  this
          Registration Statement shall become effective on such date as the
          Commission, acting pursuant to said Section 8(a), may determine.



























          <PAGE>
<PAGE>



          PROSPECTUS

                                   1,262,062 Shares        

                              THE HILLHAVEN CORPORATION

                                     Common Stock

             
               This Prospectus covers the  offering for resale of 1,262,062
          shares  (the "Shares") of common stock, par value $0.75 per share
          (the "Common Stock") of The Hillhaven Corporation ("Hillhaven" or
          the  "Company") by  the Selling  Stockholders named  herein under
          "Selling Stockholders", who  acquired their shares  in connection
          with the acquisition by Hillhaven  of Convalescent Pharmaceutical
          Services, Inc.,  a California  corporation ("CPS"), and  Advanced
          Infusion Systems,  Inc.,  a California  corporation  ("AIS",  and
          collectively with  CPS, "CPS/AIS").   Hillhaven will  not receive
          any proceeds from such resale.     

               The  Common Stock is listed  on the New  York Stock Exchange
          under the symbol HIL.

               The Shares  covered by  this Prospectus  may be  offered for
          sale from  time  to  time  on the  New  York  Stock  Exchange  or
          otherwise,  at prices then obtainable.  The Company has agreed to
          indemnify  the Selling Stockholders  against certain liabilities,
          including liabilities  under the  Securities Act.   See "Plan  of
          Distribution".

               Certain  persons  who  sell   the  Shares  covered  by  this
          Prospectus,  and any broker or dealer to or through whom any such
          person shall  such securities, may  be deemed to  be underwriters
          within the meaning of the Securities Act with respect to the sale
          of such securities.

          THESE SECURITIES  HAVE NOT  BEEN APPROVED  OR DISAPPROVED BY  THE
          SECURITIES  AND  EXCHANGE  COMMISSION  OR  ANY  STATE  SECURITIES
          COMMISSION, NOR HAS THE SECURITIES AND EXCHANGE COMMISSION OR ANY
          STATE SECURITIES COMMISSION PASSED  UPON THE ACCURACY OR ADEQUACY
          OF  THIS PROSPECTUS.  ANY  REPRESENTATION TO  THE  CONTRARY IS  A
          CRIMINAL OFFENSE. 

                   The date of this Prospectus is November 10, 1994.      





          <PAGE>
<PAGE>



                                AVAILABLE INFORMATION

               The  Company  has filed  with  the  Securities and  Exchange
          Commission (the "Commission") in Washington, D.C., a Registration
          Statement on  Form S-3 (together with all amendments and exhibits
          and   schedules  thereto,   hereinafter   referred   to  as   the
          "Registration Statement")  under the  Securities Act of  1933, as
          amended (the "Securities Act"), with respect to the  Common Stock
          offered by this Prospectus.  This Prospectus, which constitutes a
          part of the Registration  Statement, does not contain all  of the
          information  set forth  in  the  Registration Statement,  certain
          parts  of  which are  omitted in  accordance  with the  Rules and
          Regulations  of the  Commission.   For  further information  with
          respect to the Company and the Common Stock, reference is made to
          the   Registration  Statement.   Statements  contained   in  this
          Prospectus as to the contents of any contract, agreement or other
          document referred  to are not necessarily  complete; with respect
          to  each such contract, agreement  or other document  filed as an
          exhibit to the Registration Statement or otherwise filed with the
          Commission,  reference is  made  to such  contract, agreement  or
          other document for a complete description of the matter involved,
          and each such statement shall be deemed qualified in its entirety
          by such reference. 

               The Company is subject  to the informational requirements of
          the Securities  Exchange Act of  1934, as amended  (the "Exchange
          Act"),  and   in  accordance   therewith  files   reports,  proxy
          statements  and  other  information  with  the  Commission.  Such
          reports,  proxy  statements   and  other   information  and   the
          Registration Statement and exhibits  and schedules thereto  filed
          by the Company with the Commission can be inspected and copied at
          the Public  Reference Section  of the  Commission  at Room  1024,
          Judiciary Plaza, 450 Fifth  Street, N.W., Washington, D.C. 20549,
          and  at the regional offices  of the Commission  located at Seven
          World Trade Center, 13th Floor, New York,  New York 10048 and 500
          West Madison Street,  Suite 1400,  Chicago, Illinois  60661-2511.
          Copies  may also be obtained from the Public Reference Section of
          the Commission at  Room 1024, Judiciary Plaza,  450 Fifth Street,
          N.W., Washington, D.C. 20549, at prescribed rates.  Such reports,
          proxy  statements  and  other  information  filed  on  or  before
          November  1, 1993 can  also be  inspected at  the offices  of the
          American Stock  Exchange, 86  Trinity Place,  New York,  New York
          10006.   Such  reports,  proxy statements  and other  information
          filed on or  after November 2, 1993 can also  be inspected at the
          offices  of the  New York  Stock Exchange,  20 Broad  Street, New
          York, New York 10005.

                   INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

               The  following  documents,  which  have been  filed  by  the
          Company  with the  Commission,  are hereby  incorporated in  this
          Prospectus by reference and made a part hereof: 

               1.   The Company's Annual Report on Form 10-K for the fiscal
          year ended May 31, 1994;

               2.   Quarterly  Report on  Form 10-Q  for the  quarter ended
          August 31, 1994;     

          <PAGE>
<PAGE>



             
               3.   Current  Report on  Form 8-K  dated as  of October  12,
          1994; and 

               4.   The  description  of  the  purposes  and  certain anti-
          takeover effects  of certain provisions of  the Company's Amended
          and Restated Articles and  By-Laws and of the Rights  Plan, which
          is  contained in the Company's Registration  Statement on Form 10
          filed with the Commission on January 8, 1990, pursuant to Section
          12 of the Exchange Act, including any amendments or reports filed
          for the purpose of updating such description.     

               In addition, all documents filed by the Company pursuant  to
          Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent
          to the date of  this Prospectus and  prior to the termination  of
          this  offering shall be deemed to be incorporated by reference in
          this Prospectus and  to be a part hereof from  the date of filing
          of  such documents.    Any statement  contained  herein or  in  a
          document incorporated  or deemed to be  incorporated by reference
          herein  shall be deemed to be modified or superseded for purposes
          of this  Prospectus  to the  extent  that a  statement  contained
          herein  or in any other subsequently filed document that also is,
          or  is deemed to be, incorporated by reference herein modifies or
          supersedes  such statement.  Any such  statements so  modified or
          superseded  shall  not  be  deemed,  except  as  so  modified  or
          superseded, to constitute a part of this Prospectus. 

               Hillhaven will provide without charge to each person to whom
          a copy of  this Prospectus is delivered, upon the  request of any
          such  person, a copy  of any  or all  of the  foregoing documents
          incorporated  herein by  reference (other  than exhibits  to such
          documents).  Written or telephone requests should be directed to:
          The  Hillhaven   Corporation,   1148  Broadway   Plaza,   Tacoma,
          Washington 98402, Attention: Secretary, (206) 572-4901.

                                     THE COMPANY

               Hillhaven   operates   nursing   centers,   pharmacies   and
          retirement housing communities.  Based upon the number of beds in
          service  and net  operating revenues, the  Company is  the second
          largest long term care provider in the United States and believes
          that  it is  one of  the leading  providers of  Alzheimer's care.
          Pharmacy operations are  conducted through the Company's  wholly-
          owned subsidiary, Medisave Pharmacies, Inc. ("Medisave").  

               The Company provides a wide range of diversified health care
          services,  including  long term  care  and  subacute medical  and
          rehabilitation services, such as  wound care, oncology treatment,
          brain   injury  care,  stroke  therapy  and  orthopedic  therapy.
          Subacute medical  and rehabilitation services are  offered at all
          of  the Company's  nursing centers  and are  the fastest  growing
          component of the Company's  nursing center operations.  Hillhaven
          believes  that it  is  also  one  of  the  largest  providers  of
          physical, occupational and speech therapies in the United States.
          In addition,  the Company  currently provides  long term care  to
          residents of  the  Company's  nursing  centers  with  Alzheimer's
          disease through 61 Alzheimer's care units.


          <PAGE>
<PAGE>



               Unless the context otherwise requires, the terms "Hillhaven"
          and  the "Company"  refer to  The Hillhaven  Corporation and  its
          consolidated  subsidiaries.  The  Company was  incorporated under
          the laws  of  the state  of  Nevada in  May  1989. Its  principal
          offices are  located at  1148 Broadway Plaza,  Tacoma, Washington
          98402, and its telephone number is (206) 572-4901.

                                 SELLING STOCKHOLDERS

             
               Set forth below for the four individuals who acquired Shares
          in  connection with  Hillhaven's  share for  share exchange  with
          CPS/AIS  on October  31,  1994,  are  the  number  of  Shares  so
          acquired, which Shares may  be sold by such Selling  Stockholders
          hereunder  at any  time  after the  Company  releases its  second
          quarter  earnings  information  which  will include  30  days  of
          combined earnings of the  Company and CPS and  AIS.  The  Company
          plans to release  this earnings information on or  about December
          21, 1994.     

                                                            SHARES OWNED

               Willis D. Corkern and Lela K. Corkern,       344,763
               Co-Trustees of The Corkern Living Trust
               UTA dated April 1, 1993

               Melvin K. Kahn and Madeline J. Kahn,         344,763
               Co-Trustees of The Kahn Living Trust
               UTA dated April 24, 1992

               Stanley and Linda Poncetta, husband and      254,160
               wife, as community property

               Willis D. Corkern and Lela K. Corkern,       45,305
               Co-Trustees of The Corkern Unitrust
               U/T/A dated September 30, 1994

               Melvin K. Kahn and Madeline J. Kahn,         45,305
               Co-Trustees of The Kahn Unitrust
               U/T/A dated September 19, 1994

               Stanley E. Poncetta and Linda A. Poncetta,   135,908
               Co-Trustees of The Poncetta Unitrust
               U/T/A dated September 30, 1994

               Karen A. Flores                              91,858     

                                 PLAN OF DISTRIBUTION

               The  Company is not aware  of any plan  of distribution with
          respect to the Selling Stockholders.   Distribution of the Shares
          by the Selling Stockholders may be effected from  time to time in
          one or  more transactions (which may  involve block transactions)
          (i)  on the New York Stock Exchange, (ii) in the over-the-counter
          market, (iii) in  transactions otherwise than on such exchange or
          in  the over-the-counter market or  (iv) in a  combination of any
          such transactions.    Such transactions  may be  effected by  the
          Selling Stockholders at market prices prevailing at the time of 

          <PAGE>
<PAGE>



          sale,  at prices  related to  such prevailing  market  prices, at
          negotiated prices or  at fixed prices.   The Selling Stockholders
          may effect  such  transactions by  selling Shares  to or  through
          broker-dealers,  and such broker-dealers may receive compensation
          in  the  form  of  discounts  or  commissions  from  the  Selling
          Stockholders and  may receive commissions from  the purchasers of
          Shares for whom they may act as agent.  Pursuant to the Agreement
          and  Plan of  Reorganization among  the Selling  Stockholders and
          Hillhaven dated as of  October 11, 1994, Hillhaven has  agreed to
          indemnify   the  Selling   Stockholders  against   certain  civil
          liabilities, including liabilities under the Securities Act.

                             DESCRIPTION OF COMMON STOCK

               The summary of the attributes  of the Company's Common Stock
          set forth below does not purport to be complete and is subject to
          and qualified in  its entirety  by reference to  the Amended  and
          Restated Articles of Incorporation  of Hillhaven (the "Articles")
          and  the  Amended and  Restated  By-Laws of  Hillhaven  (the "By-
          Laws"), copies of which are exhibits to documents incorporated by
          reference  herein.   See "Incorporation  of Certain  Documents by
          Reference."

               Under  the  Articles, the  total  amount  of shares  of  all
          classes of  stock that the  Company has authority to  issue is 85
          million  shares, of  which  25 million  are  shares of  Preferred
          Stock,  par value $0.15 per share (the "Preferred Stock"), and 60
          million are shares of Common Stock.

               Subject  to the  limitations provided  pursuant  to Sections
          78.378 through 78.3793 (the "Control Shares Acquisition Statute")
          of  the Private  Corporation  Law of  the  State of  Nevada,  the
          holders of  Common Stock  will be entitled  to one vote  for each
          share  on  all  matters   voted  on  by  stockholders,  including
          elections of directors, and, except as otherwise required  by law
          or provided in any  resolution adopted by the Board  with respect
          to any series or  class of Preferred  Stock, the holders of  such
          shares will exclusively  possess all voting power.   The Articles
          do  not  provide  for  cumulative  voting  for  the  election  of
          directors.  Subject to any preferential rights of any outstanding
          series  of Preferred Stock designated  by the Board  from time to
          time,  the holders  of  Common Stock  will  be entitled  to  such
          dividends as may be declared from time to time by  the Board, and
          upon liquidation  will  be  entitled  to receive  all  assets  of
          Hillhaven available for distribution to such holders.

               The Board of Directors of the Company is authorized to issue
          Preferred Stock, in one or more series or classes, and to fix for
          each  such  series or  class  such  voting powers,  designations,
          preferences  and  relative,   participating,  optional  or  other
          special   rights   and   such   qualifications,   limitations  or
          restrictions,  as are  stated  in the  resolution or  resolutions
          adopted by the  Board providing for  the issue of such  series or
          class and  as are permitted by Nevada law.  The Board could issue
          Preferred Stock having terms which could discourage a takeover or
          other transaction that  some, or a majority,  of the stockholders
          might believe to be in their best interests or in which 
          stockholders might receive a premium for their stock over the 
          then market price of such stock.
          <PAGE>
<PAGE>



               Certain of the  Company's debt agreements contain  covenants
          restricting the payment of cash dividends on the Company's Common
          Stock.    Under  the  most restrictive  of  these  covenants, the
          payment  of  any cash  dividends  would have  been  prohibited at
          August 31, 1994.

               No holder of  any stock of any class has  any pre-emptive or
          preferential right  to acquire or  subscribe for any  treasury or
          unissued   shares  of  any  class  of  stock  or  any  authorized
          securities  convertible into  or  carrying any  right, option  or
          warrant to subscribe for or acquire shares of any class of stock.

               Transfer Agent and Registrar

               The transfer  agent and  registrar for  the Common  Stock is
          Chemical Trust Company of California.

                                    LEGAL MATTERS

                    The validity of the Common Stock offered hereby will be
          passed upon for  the Company  by Richard P.  Adcock, Senior  Vice
          President, Secretary and General  Counsel of the Company.   As to
          matters  governed by  the  laws  of  the  State  of  Nevada,  the
          Company's General  Counsel will rely  on Woodburn and  Wedge, One
          East First Street, Suite 1600, Reno, Nevada. 

               As  of September 30, 1994, Mr. Adcock owned 50,298 shares of
          the Company's  Common  Stock,  of which  13,742  are  subject  to
          forfeiture under certain circumstances.   In addition, Mr. Adcock
          held  options  to  purchase  an additional  5,916  shares  of the
          Company's Common Stock pursuant to the 1990 Stock Incentive  Plan
          and options to  purchase an  aggregate of 184,590  shares of  the
          Company's  Common Stock  pursuant  to the  Performance Investment
          Plan.    Mr. Adcock  also has  an  interest in  5,916 Performance
          Shares (reflects 100% of the target award) awarded under the 1990
          Stock  Incentive  Plan, which  he  is  eligible  to receive  with
          respect  to the three-year periods  ending May 31,  1995, May 31,
          1996 and May 31, 1997. 

                                       EXPERTS

               The consolidated financial  statements and schedules  of The
          Hillhaven Corporation and its subsidiaries as of May 31, 1994 and
          1993 and for each of the years in the three year period ended May
          31, 1994, in the Company's annual  report on Form 10-K, have been
          incorporated  by reference herein in  reliance upon the report of
          KPMG Peat Marwick LLP, independent certified public  accountants,
          incorporated by reference herein, and upon the  authority of said
          firm as experts in accounting and auditing.

               The report of  KPMG Peat  Marwick LLP covering  the May  31,
          1994 consolidated financial statements refers to  a change in the
          method  of  providing  income  taxes  by  adopting  Statement  of
          Financial Accounting  Standards No. 109,  "Accounting for  Income
          Taxes".


          <PAGE>
<PAGE>



               No  person has been authorized to give any information or to
          make any representation not contained  in this Prospectus and, if
          given  or made, such  information or  representation must  not be
          relied  upon as having been authorized.  This Prospectus does not
          constitute an offer of  any securities other than the  registered
          securities to which it relates  or an offer to any person  in any
          jurisdiction where such offer would be unlawful.  The delivery of
          this  Prospectus at  any  time does  not  imply that  information
          herein is correct as of any time subsequent to its date.

                                  TABLE OF CONTENTS

                                                                 Page  

               Available Information                             2   
               Incorporation of Certain Documents by Reference   2   
               The Company                                       3   
               Selling Stockholders                              4   
               Plan of Distribution                              4   
               Description of Common Stock                       5   
               Legal Matters                                     6   
               Experts                                           6   

                              THE HILLHAVEN CORPORATION

                                     Common Stock


                                      PROSPECTUS


                                 November 10, 1994      






















          <PAGE>
<PAGE>



                                       PART II
                        INFORMATION NOT REQUIRED IN PROSPECTUS

          Item 14.  Other Expenses of Issuance and Distribution

               The following is an itemized  statement of the expenses (all
          but the SEC fees  are estimates) in connection with  the issuance
          and  distribution of the Shares being  registered hereunder.  All
          such expenses will be borne by the Company.

               SEC filing fee                     $ 9,621.00
               Accountants' fees and expenses       5,000.00
               Legal fees and expenses              5,000.00
               Miscellaneous                        3,379.00
                                                  ----------
               Total                              $23,000.00
                                                  ==========

          Item 15.  Indemnification of Directors and Officers

               Nevada law  and the Company's Amended  and Restated Articles
          of  Incorporation  and   Amended  and  Restated  By-Laws   permit
          indemnification of directors and  officers in terms  sufficiently
          broad   to  indemnify  officers   and  directors   under  certain
          circumstances for liabilities  (including expense  reimbursement)
          arising  under  the  Securities  Act  of  1933,  as amended  (the
          "Securities Act").  The Company also maintains an indemnification
          agreement  with each of its  directors and any officer designated
          by the Company's Board of Directors insuring them against certain
          liabilities incurred by them in the performance  of their duties,
          including liabilities under the Securities Act.  In addition, the
          Company has directors and officers liability insurance policies.

          Item 16.  Exhibits

               The  following  Exhibits   are  filed  or  incorporated   by
          reference in this Registration Statement: 

           3.01     Amended  and  Restated  Articles  of  Incorporation  of
                    Registrant (Incorporated  by reference to  Exhibit J to
                    Exhibit 2 to Registrant's Quarterly Report on Form 10-Q
                    for the quarter ended November 30, 1989, as amended)
           3.02     Amended    and    Restated   By-Laws    of   Registrant
                    (Incorporated   by  reference   to   Exhibit  3.02   to
                    Registrant's Annual  Report on  Form 10-K for  the year
                    ended May 31, 1994)

             
           5.01     Opinion of Richard P. Adcock*     

             
           5.02     Opinion of Woodburn and Wedge*     

          23.01     Consent of KPMG Peat Marwick LLP
          23.02     Consent of Richard P. Adcock (included in Exhibit 5.01)
          23.03     Consent  of  Woodburn and  Wedge  (included in  Exhibit
                    5.02)
          <PAGE>
<PAGE>



             
          24.01     Power of  Attorney (included  in signature page  to the
                    Registration Statement)*     

               * Previously filed.     

          Item 17.  Undertakings

               The undersigned Registrant hereby undertakes:

               (a)(1)  To  file, during any period in which offers or sales
          are being  made, a post-effective amendment  to this registration
          statement:

                    (i)   To  include  any prospectus  required by  Section
               10(a)(3) of the Securities Act of 1933;

                    (ii)   To reflect in the prospectus any facts or events
               arising  after  the  effective  date  of  the   registration
               statement (or most  recent post-effective amendment thereof)
               which,   individually  or  in  the  aggregate,  represent  a
               fundamental  change  in the  information  set  forth in  the
               registration statement;

                    (iii)  To include any material information with respect
               to the plan of distribution not previously disclosed  in the
               registration  statement  or  any  material  change  to  such
               information in the registration statement;

          provided, however,  that paragraphs  (a)(1)(i) and (a)(1)(ii)  do
          not apply  if the information required to  be included in a post-
          effective amendment by those  paragraphs is contained in periodic
          reports filed by the  Registrant pursuant to Section 13  or 15(d)
          of the Securities Exchange  Act of 1934 that are  incorporated by
          reference in the registration statement.

               (2)   That,  for the  purpose of  determining  any liability
          under  the  Securities  Act  of 1933,  each  such  post-effective
          amendment shall  be  deemed to  be a  new registration  statement
          relating to  the securities offered therein, and  the offering of
          such  securities at that  time shall be deemed  to be the initial
          bona fide offering thereof.

               (3)    To  remove from  registration  by  means  of a  post-
          effective amendment any of  the securities being registered which
          remain unsold at the termination of the offering.

               (4)  That, for purposes  of determining any liability  under
          the  Securities  Act of  1933,  each filing  of  the Registrant's
          annual  report   pursuant  to  Section  13(a)  or  15(d)  of  the
          Securities Exchange Act of 1934 that is incorporated by reference
          in  this registration  statement  shall be  deemed  to be  a  new
          registration  statement   relating  to  the   securities  offered
          therein, and the offering  of such securities at that  time shall
          be deemed to be the initial bona fide offering thereof.

          <PAGE>
<PAGE>



               (b)  Insofar  as  indemnification  for  liabilities  arising
          under the Securities Act  of 1933 may be permitted  to directors,
          officers and  controlling persons  of the Registrant  pursuant to
          the foregoing  provisions, or otherwise, the  Registrant has been
          advised  that  in  the opinion  of  the  Securities  and Exchange
          Commission  such  indemnification  is against  public  policy  as
          expressed in the  Act and  is, therefore,  unenforceable. In  the
          event  that  claim for  indemnification against  such liabilities
          (other than the payment by the Registrant of expenses incurred or
          paid  by  a  director,  officer  or  controlling  person  of  the
          Registrant  in the  successful  defense of  any  action, suit  or
          proceeding) is asserted by  such director, officer or controlling
          person in  connection with  the securities being  registered, the
          Registrant  will, unless in the opinion of its counsel the matter
          has been settled by  controlling precedent, submit to a  court of
          appropriate    jurisdiction    the    question    whether    such
          indemnification by  it is against  public policy as  expressed in
          the Act  and will be governed  by the final adjudication  of such
          issue. 





































          <PAGE>
<PAGE>



                                      SIGNATURES

             
               Pursuant to the requirements of the Securities Act of  1933,
          the  Registrant  certifies  that  it has  reasonable  grounds  to
          believe that it meets  all of the requirements for filing on Form
          S-3, and has duly caused this Amendment No. 1 to the Registration
          Statement to be signed on its behalf by the undesigned, thereunto
          duly authorized, in the  City of Tacoma, State of  Washington, on
          November 8, 1994.       

                                             THE HILLHAVEN CORPORATION

                                             By:  /s/ RICHARD P. ADCOCK    
                                                  Richard P. Adcock
                                                  Senior Vice President
                                                  and Secretary

               Pursuant to the  requirements of the Securities Act of 1933,
          this  Amendment No.  1  to the  Registration  Statement has  been
          signed  below by the following  persons in the  capacities and on
          the dates indicated.     

          SIGNATURES                 TITLE            DATE

             
               *              Chief Executive     November 8, 1994
          (Bruce L. Busby)Officer and Chairman
                             of the Board

               *               Director           November 8, 1994
          (Walter F. Beran)

               *               Director           November 8, 1994
          (Peter de Wetter)

               *              President           November 8, 1994
          (Chris Marker)     and Director

               *                Director          November 8, 1994
          (Dinah Nemeroff)

               *               Director           November 8, 1994
          (Jack O. Vance)

               *               Director           November 8, 1994
          (Maris Andersons)
              
          <PAGE>
<PAGE>



             
               *        Senior Vice President     November 8, 1994 
          (Robert F. Pacquer)and Chief Financial 
                                Officer

               *          Vice President and      November 8, 1994 
          (Michael B. Weitz)Principal Accounting
                                Officer 
                                                                           
                                                                           
                                                    
          *   By:   /s/ Richard P. Adcock
                    Richard P. Adcock
                    Attorney-in-fact     








































          <PAGE>
<PAGE>



                                     EXHIBIT LIST

          Exhibit
            No.     Description

           3.01     Amended  and  Restated  Articles  of  Incorporation  of
                    Registrant (Incorporated by  reference to Exhibit  J to
                    Exhibit 2 to Registrant's Quarterly Report on Form 10-Q
                    for the quarter ended November 30, 1989, as amended)
           3.02     Amended    and    Restated   By-Laws    of   Registrant
                    (Incorporated   by  reference   to   Exhibit  3.02   to
                    Registrant's Annual  Report on  Form 10-K for  the year
                    ended May 31, 1994)

             
           5.01     Opinion of Richard P. Adcock *     

             
           5.02     Opinion of Woodburn and Wedge *     

          23.01     Consent of KPMG Peat Marwick LLP
          23.02     Consent of Richard P. Adcock (included in Exhibit 5.01)
          23.03     Consent  of  Woodburn  and Wedge  (included  in Exhibit
                    5.02)

             
          24.01     Power of  Attorney (included  in signature page  to the
                    Registration Statement)     

               *  Previously filed.     
























          <PAGE>
<PAGE>






          Exhibit 23.01


          KPMG Peat Marwick LLP
               Certified Public Accountants

               3100 Two Union Square
               601 Union Street
               Seattle, WA 98101-2327




                            INDEPENDENT AUDITORS' CONSENT



          The Board of Directors
          The Hillhaven Corporation:


          We consent to incorporation by reference in the Registration
          Statement on Form S-3 of The Hillhaven Corporation of our report
          dated July 8, 1994, relating to the consolidated balance sheets
          of The Hillhaven Corporation and subsidiaries as of May 31, 1994
          and 1993, and the related consolidated statements of operations,
          cash flows, and stockholders' equity for each of the years in the
          three-year period ended May 31, 1994, and all related schedules,
          which report appears in the May 31, 1994 annual report on Form
          10-K of The Hillhaven Corporation and to the reference to our
          firm under the heading "Experts" in the prospectus.

          Our report refers to a change in the method of accounting for
          income taxes effective June 1, 1992.




                                        /s/ KPMG Peat Marwick LLP
                                        KPMG Peat Marwick LLP     




          Seattle, Washington

             
          November 8, 1994     










          <PAGE>
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission